11.29.09

Bayer Sets Drospirenone Loose on America through Ocella

Posted in Activists, Online Health, The Lawyers Way at 4:21 am

Yaz is a popular birth control pill that is taken by millions of women around the world every year. As of late, Yaz has been affiliated with certain serious Yaz side effects and possibly life-threatening injuries. Women taking Yasmin, or its generic form Ocella, have reportedly suffered strokes, heart attacks, among other serious health problems. And on top of the already rising scrutiny, the FDA has sanctioned the makers of Yaz and Yasmin for misleading television ads that did not properly informing consumers and misinterpreted the conditions the pills were meant to treat.

Among the different disputes impending on Yasmin, Yaz and Ocella birth control, the drugs also include drospirenone, an element not in other oral contraceptives. The British Medical Journal issued studies in August 2009 diplaying an increased risk of venous blood clots in young women taking drospirenone as opposed to those who used other oral contraceptives. In that same month, the FDA issued an unrelated advisory to Bayer Pharmaceuticals, makers of Yasmin, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and well-being, these research studies have been made available free online.

Little know birth control side effects such as Cerebral Venous Sinus Thrombosis and even death have also been reported as a result of using Ocella, Yasmin and Yaz. With the clinical studies available on the internet, it is more important than ever to arm yourself with knowledge before determining if a pharaceutical is right for you. Something as ubiquitous as ‘the pill’ can cause serious damage or even kill you if you are not careful.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • OnlyWire
  • Socialize-It
  • Digg
  • del.icio.us
  • Reddit
  • RawSugar
  • YahooMyWeb
  • Ma.gnolia
  • Netscape
  • Slashdot
  • Furl
  • StumbleUpon

Sorry, comments are closed.